ADHERA THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1983-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.adherathera.com
Phase II Trial of Niraparib-Dostarlimab Combination Fails to Meet Primary Endpoint in Recurrent Head and Neck Cancer
A phase II trial evaluating niraparib and dostarlimab combination therapy in recurrent/metastatic head and neck squamous cell carcinoma was terminated early for futility after achieving only 20% clinical benefit versus the target of 50%.